In addition to impairments in glycaemic control and insulin action, NAFLD is associated with dyslipidaemia, including increased plasma triglyceride and low-density lipoprotein (LDL) cholesterol, and decreased high-density lipoprotein (HDL) cholesterol, with all being risk factors for cardiovascular disease21. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.